甲硅烷基烯醇醚5和β-内酰胺9(R = Me 3 Si)偶联得到酮13a-d。化合物13a,13c和13d转化为三环内酰胺16-20、23-25。(光学纯的甲硅烷基烯醇醚5的化学酶法合成可得到同手性内酰胺23-25。)此外,酮氮杂环丁酮13被保护为1,3-恶唑烷30。使用Bouffard方法进行所需的立体化学反应,得到醇32。形成相应的碳酸硝基苄酯,脱保护和氧化提供了酮35a和35b,其随后分别转化为三苯甲基41a和41b。
甲硅烷基烯醇醚5和β-内酰胺9(R = Me 3 Si)偶联得到酮13a-d。化合物13a,13c和13d转化为三环内酰胺16-20、23-25。(光学纯的甲硅烷基烯醇醚5的化学酶法合成可得到同手性内酰胺23-25。)此外,酮氮杂环丁酮13被保护为1,3-恶唑烷30。使用Bouffard方法进行所需的立体化学反应,得到醇32。形成相应的碳酸硝基苄酯,脱保护和氧化提供了酮35a和35b,其随后分别转化为三苯甲基41a和41b。
The stereoselective synthesis of a key intermediate of the trinem antibiotic sanfetrinem
作者:Chiara Ghiron、Elisabetta Piga、Tino Rossi、Bruno Tamburini、Russell J. Thomas
DOI:10.1016/0040-4039(96)00682-x
日期:1996.5
By modulating the reactivity of the Lewis acid promoter it was possible to obtain, in a single stereoselective condensation step, the methoxyketone 7, an advanced intermediate in the synthesis of Sanfetrinem GV104326.
hydrogenation of racemic 5 using ruthenium-BINAP-diamine-KOH system, followed by oxidation. Magnesium enolate of (2S)-2-methoxycyclohexanone [(S)-5] reacts with the 4-acetoxyazetidinone 4 to give the key intermediate 3 with high yield and diastereoselectivity for the synthesis of sanfetrinem 1.
New trinem antibiotics and inhibitors of beta-lactamases
申请人:LEK Pharmaceuticals d.d.
公开号:EP2135871A1
公开(公告)日:2009-12-23
The present invention relates to a compound of formula (I)
in particular compounds of formula (Ia),
the use of a therapeutically effective amount of one or more compounds of formula (I) or (Ia) as a broad-spectrum antibiotic and the use of a pharmaceutical composition comprising said compounds for the treatment of bacterial infections in humans or animals.
Stereoselective synthesis of fluorine-containing analogues of anti-bacterial sanfetrinem and LK-157
作者:Barbara Mohar、Michel Stephan、Uroš Urleb
DOI:10.1016/j.tet.2010.03.104
日期:2010.6
The synthesis of (1′S,3R,4R)-4-acetoxy-3-(1′-trimethylsilyloxy-2′,2′,2′-trifluoroethyl)-2-azetidinone (10) precursor of modified carbapenems is described relying upon [Ru(C6Me6)(S,S)–(CH2)5NSO2DPEN]-catalyzed asymmetric transfer hydrogenation under dynamic kinetic resolution using HCO2H–Et3N. This fluorine-containing precursor yielded the targeted trinems 1 and 2 via a stereoselective key step condensation
A process for producing cyclohexylazetidinone expressed by the formula(IV) comprises condensing the magnesium enolate compound expressed by the formula (II) with acyloxyazetidinone expressed by the formula (III), wherein Me is a methyl group; R.sup.1 is a hydroxyl-protecting group, R.sup.2 is an acyl group, and X is a halogen atom. ##STR1##